Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macrolides in refractory asthma
ISRCTN93221282Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Jan 2009
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of azithromycin in asthma (2 arms), sponsored by University of Nottingham. Primary endpoint: Bronchial reactivity. Started Jan 2009; status: completed.
02
Drugs
azithromycin
03
Conditions
asthma
Beyond the preview
Go deeper on ISRCTN93221282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN93221282.